For sure.
This is the start of a very significant and substantial upward movement in AHZ's share price and it will be ALL DUE to the company's performance.
There are very very big things happening internally for Admedus, ADAPT, Infusion business and the immunotherapies divisions and we will be re-rated accordingly. If you understand the nature of this business and its prospects you'll also understand this is an uptrend in investor sentiment and company valuation which could possibly go on for years.
AHZ chart, page-615
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.20 |
Change
-0.200(1.09%) |
Mkt cap ! $349.8M | |||
| Open | High | Low | Value | Volume |
| $18.50 | $18.50 | $18.00 | $77.59K | 4.263K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 206 | $18.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.70 | 34 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |